- Share Prices
Theracryf PLC (TCF)
0.26p+0.00 (+0.00%)04 Jul 2025, 09:21
Theracryf PLC Market & Company News
| 02.07.2025 15:45 | YNGA, TCF, MII | UK shareholder meetings calendar - next 7 days | Alliance |
| 16.06.2025 16:10 | TCF | Notice of AGM | RNS |
| 13.06.2025 07:00 | TCF | Change of Adviser | RNS |
| 10.06.2025 12:32 | TCF | Ox-1 Investor Presentation | Reach |
| 03.06.2025 13:37 | TCF | TheraCryf confident as loss narrows but posts no revenue for 2025 | Alliance |
| 03.06.2025 07:00 | TCF | Final results for year to 31 March 2025 | RNS |
| 27.05.2025 16:20 | FERG, TCF, PNN | UK earnings, trading statements calendar - next 7 days | Alliance |
| 23.05.2025 07:14 | TCF | Notice of Results and Ox-1 presentation | RNS |
| 22.05.2025 12:43 | TCF | Holding(s) in Company | RNS |
| 22.05.2025 12:22 | TCF | Director/PDMR Shareholding | RNS |
| 16.05.2025 13:00 | TCF | Holding(s) in Company | RNS |
| 12.05.2025 18:23 | TCF | TheraCryf partners with Pharmaron to develop addiction programme | Alliance |
| 12.05.2025 07:00 | TCF | Master Service Agreement signed for Ox-1 programme | RNS |
| 01.05.2025 07:00 | TCF | Board Appointment, Grant of Options, PDMR Dealing | RNS |
| 26.03.2025 07:00 | TCF | Investor webinar | Reach |
| 21.03.2025 15:55 | TCF | Holding(s) in Company | RNS |
| 20.03.2025 15:33 | TCF | Holding(s) in Company | RNS |
| 20.03.2025 11:01 | TCF | Holding(s) in Company | RNS |
| 19.03.2025 12:10 | TCF | Holding(s) in Company | RNS |
| 17.03.2025 14:17 | TCF | Holding(s) in Company | RNS |
| 17.03.2025 07:00 | TCF | Holding(s) in Company | RNS |
| 17.03.2025 07:00 | TCF | Holding(s) in Company | RNS |
| 17.03.2025 07:00 | TCF | Holding(s) in Company | RNS |
| 13.03.2025 07:00 | TCF | Holding(s) in Company | RNS |
| 12.03.2025 14:03 | TCF | Holding(s) in Company | RNS |
| 12.03.2025 13:59 | TCF | Holding(s) in Company | RNS |
| 11.03.2025 10:17 | TCF | Holding(s) in Company | RNS |
| 07.03.2025 12:04 | TCF | Result of General Meeting | RNS |
| 04.03.2025 12:00 | TCF | Director/PDMR Shareholding | RNS |
| 24.02.2025 16:31 | TCF | Holding(s) in Company | RNS |
| 19.02.2025 11:04 | TCF | £4.25m Placing and Subscription, Notice of GM | RNS |
| 19.02.2025 10:54 | TCF | Appointment of Dr Alastair Smith as Chair | RNS |
| 28.11.2024 14:25 | TCF | TheraCryf narrows loss, advances drug programmes after acquisition | Alliance |
| 28.11.2024 07:00 | TCF | Half-year Report | RNS |
| 27.11.2024 12:16 | TCF | TheraCryf gets European patent for drug acquired from new subsidiary | Alliance |
| 27.11.2024 07:00 | TCF | European Patent Office award decision | Reach |
| 21.11.2024 16:15 | TCF, TPX, LTHM | UK earnings, trading statements calendar - next 7 days | Alliance |
| 15.11.2024 10:58 | TCF | Holding(s) in Company | RNS |
| 14.11.2024 15:24 | TCF | Issue of Equity and Total Voting Rights | RNS |
| 14.11.2024 11:00 | TCF | Notice of Results | RNS |
| 11.11.2024 07:00 | TCF | Publication of peer reviewed data | Reach |
| 04.11.2024 15:43 | PFD, EJFI, SDG | EXECUTIVE CHANGES: Sanderson hires in UK and US; Oberon gets Penny | Alliance |
| 04.11.2024 11:00 | TCF | Passing of Dr Sue Foden, Chair | RNS |
| 29.08.2024 07:00 | TCF | Grant of Options and PDMR Dealings | RNS |
| 08.08.2024 10:23 | TCF | Holding(s) in Company | RNS |
